Amylyx Pharmaceuticals (AMLX) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.75
-1.02
-0.29
0.44

Details

Expected EPS
-0.73
Actual EPS
-1.07
Surprise EPS
-0.34
Surprise Percent
+46.58%

Description

Amylyx Pharmaceuticals (AMLX) has reported earnings of -1.07 per share for Q3 2024.

0 Comments

Share your thoughts